all report title image
  • To Be Published : Feb 2024
  • Code : CMI223
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under the skin of the patient to monitor the user’s heart rate. ICDs are connected to the heart by thin wires. In cases where an abnormal heart beat is detected, implantable cardioverter-defibrillator deliver an electric shock to reinstate a normal heart rhythm if the patient’s heart is beating too fast. Implantable cardioverter-defibrillators have been useful in thwarting sudden deaths in patients with fibrillation or sustained ventricular tachycardia. Various studies have shown that they may prevent cardiac arrest in patients who are at a high risk of life-threatening ventricular arrhythmias. An implantable cardioverter -defibrillator senses when the heart rhythm is not normal and it tries to make the heart rhythm normal. If the device has a pacemaker feature incorporated, it works as a pacemaker when the heartbeat is slow, and transmit tiny electric signals to the heart. However, when the heartbeat is very chaotic or fast, the device gives defibrillation shocks in order to restrain the abnormal rhythm. Implantable cardioverter-defibrillators work for 24 hours a day.

According to Centers for Disease Control and Prevention (CDC), it is estimated that around 2.7–6.1 million individuals in the U.S. suffered from atrial fibrillation in 2015. The report suggests that the number of occurrences is likely to increase with the increase in number of aging of the population in this region. Roughly 2% of the population who are younger than 65 years of age suffers from AF. However, around 9% of the population with 65 years of age or more suffers from AF. Increasing cases of AF among the global population coupled with advancement in technology will drive the implantable cardioverter-defibrillators market during the forecast period.

Implantable Cardioverter-defibrillators Market Taxonomy

On the basis of type of product, the global market is classified into:

  • Biventricular Implantable Cardioverter Defibrillators
  • Single Chambered
  • Dual Chambered

On the basis of type of procedure, the global market is classified into:

  • Subcutaneous Implantable Cardioverter Defibrillators
  • Trans-Venous Implantable Cardioverter Defibrillators

On the basis of end user, the global market is classified into:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the device is laired under the skin more willingly than inside the heart. Some of the advantages of the S-ICD are the lack of immediate or long-term complications caused by inserting a lead into the heart, such as collapse of the lung and perforation of the heart. Subcutaneous implantable cardioverter defibrillators are the main driver for the global ICD market due to the aforementioned reasons. The rise in adoption of S-ICDs will propel the overall implantable cardioverter-defibrillators market in the forecast period.

High prevalence of arrhythmia will drive the overall implantable cardioverter-defibrillators market

The rising old age population and high occurrence of coronary artery diseases are some of the major factors which will propel growth of the implantable cardioverter-defibrillators market. Sedentary lifestyles, unhealthy dietary habits, and lack of proper exercise have resulted into the increased incidences of heart related diseases, especially arrhythmia. The demand for ICDs is rising significantly as healthcare professionals and the governing bodies such as American Heart Association have widely accepted this form of treatment due to its safety, and efficacy. However, the AHA recommends that the arrhythmia in question ought to be life threatening for the patient to be eligible for a cardioverter defibrillator.

North America held the maximum market share in implantable cardioverter defibrillator market globally.  Favorable and constructive policies and regulations as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of implantable cardioverter-defibrillators from the governing bodies are likely to fuel the growth of the implantable cardioverter-defibrillators industry in this region.

Some of the key players operating in the global implantable cardioverter-defibrillators market are Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and MRI Interventions, Inc.

Key Developments

  1. Major companies in the market are focused on various business strategies such as merger and acquisition, in order to gain competitive edge in the global market. For instance, in April 2018, MicroPort Scientific Corporation, a medical device developer, acquired Cardiac Rhythm Management (CRM) Business from LivaNova Plc. Upon acquisition CRM Business is now renamed as MicroPort CRM.
  2. Key players in the market are involved in various growth strategies such as research and development, in order to expand their product portfolio. For instance, in May 2019, Medtronic plc, a medical device manufacturer, announced pilot study results for its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD). In this device, the lead is placed outside the heart and veins to provide lifesaving defibrillation.
  3. Key players in the market are involved in different growth strategies such as gaining approval from regulatory authorities, in order to expand their product portfolio. For instance, in September 2017, Abbott Laboratories, a pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-labeling for one of company’s most widely used implantable cardioverter defibrillator (ICD) and related high voltage.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount

Reliability and Reputation

DUNS Registered
DMCA Protected


Reliability and Reputation


Reliability and Reputation


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo